Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Journal Article
Bakela, K., Kountourakis N., Aivaliotis M., & Athanassakis I. (2015).  Soluble MHC-II proteins promote suppressive activity in CD4 + T cells. Immunology. 144(1), 158 - 169.
Memmos, E., Sarafidis P., Pateinakis P., Tsiantoulas A., Faitatzidou D., Giamalis P., et al. (2019).  Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis.. BMC Nephrol. 20(1), 217.
Tsalikidis, C., Papachristou F., Pitiakoudis M., Asimakopoulos B., Trypsianis G., Bolanaki E., et al. (2013).  Soluble E-cadherin as a diagnostic and prognostic marker in gastric carcinoma.. Folia Med (Plovdiv). 55(3-4), 26-32.
Nomikou, E., Alexopoulou A., Vasilieva L., Agiasotelli D., Pavlou E., Theodossiades G., et al. (2015).  Soluble CD146, a novel endothelial marker, is related to the severity of liver disease.. Scand J Gastroenterol. 50(5), 577-83.
Lazaridou, E., Fotiadou C., Patsatsi A., Fotiadu A., Kyrmanidou E., Kemanetzi C., et al. (2014).  Solitary trichoepithelioma in an 8-year-old child: clinical, dermoscopic and histopathologic findings.. Dermatol Pract Concept. 4(2), 55-8.
Tryfon, S., Dramba V., Zoglopitis F., Iakovidis D., Sakkas L., Kontakiotis T., et al. (2012).  Solitary papillomas of the lower airways: epidemiological, clinical, and therapeutic data during a 22-year period and review of the literature.. J Thorac Oncol. 7(4), 643-8.
Paramythiotis, D., Kofina K., Bangeas P., Tsiompanou F., Karayannopoulou G., & Basdanis G. (2016).  Solitary fibrous tumor of the pancreas: Case report and review of the literature.. World J Gastrointest Surg. 8(6), 461-6.
Hohenforst-Schmidt, W., Grapatsas K., Dahm M., Zarogoulidis P., Leivaditis V., Kotoulas C., et al. (2017).  Solitary fibrous tumor: A center's experience and an overview of the symptomatology, the diagnostic and therapeutic procedures of this rare tumor.. Respir Med Case Rep. 21, 99-104.
Senicourt, L., Duma L., Papadopoulos V., & Lacapère J-J. (2017).  Solid-State NMR of Membrane Protein Reconstituted in Proteoliposomes, the Case of TSPO.. Methods Mol Biol. 1635, 329-344.
Sotiriadou, S., Kyparos A., Albani M., Arsos G., Clarke M. S. F., Sidiras G., et al. (2006).  Soleus muscle force following downhill running in ovariectomized rats treated with estrogen.. Appl Physiol Nutr Metab. 31(4), 449-59.
Christodoulou, A., Terzidis I., Natsis K., Gigis I., & Pournaras J. (2004).  Soleus accessorius, an anomalous muscle in a young athlete: case report and analysis of the literature.. Br J Sports Med. 38(6), e38.
Drăghici, G. Andrei, Dehelean C., Pinzaru I., Bordean D. Maria, Borozan A., Tsatsakis A. Michael, et al. (2019).  Soil copper uptake by land snails: A semi-field experiment with juvenile Cantareus aspersus snails.. Environ Toxicol Pharmacol. 72, 103243.
Demiri, E. C., Dionyssiou D. D., Pavlidis L. C., Papas A. V., Kostogloudis N. H., & Lykoudis E. G. (2013).  Soft tissue reconstruction of the thumb with the dorsoradial forearm flap.. J Hand Surg Eur Vol. 38(4), 412-7.
Demiri, E. C., Dionyssiou D. D., Pavlidis L. C., Papas A. V., Kostogloudis N. H., & Lykoudis E. G. (2013).  Soft tissue reconstruction of the thumb with the dorsoradial forearm flap. Journal of Hand Surgery (European Volume). 3838249(4), 412 - 417.
Panagopoulou, P., Fotoulaki M., Tsitouridis I., & Nousia-Arvanitakis S. (2007).  Soft tissue inflammation: presenting feature of Crohn's disease in a cystic fibrosis adolescent.. J Cyst Fibros. 6(5), 366-8.
Imprialos, K. P., Stavropoulos K., & Doumas M. (2018).  Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs.. Cardiovasc Hematol Disord Drug Targets. 18(2), 83-85.
Patoulias, D., & Papadopoulos C. (2020).  Sodium-glucose co-transporter-2 inhibitors, cardiovascular outcomes and the impact of gender: Class effect or statistical play of chance?.
Sarafidis, P., & Papagianni A. (2019).  Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections.. Ann Intern Med. 171(12), 943-944.
Imprialos, K. P., Sarafidis P. A., & Karagiannis A. I. (2015).  Sodium-glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class?. J Hypertens. 33(11), 2185-97.
Stavropoulos, K., Imprialos K. P., Stavropoulos N., Bouloukou S., Kerpiniotis G., Dimitriadis K., et al. (2018).  Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease.. Cardiovasc Hematol Disord Drug Targets. 18(2), 120-126.
Koufakis, T., Metallidis S., Zebekakis P., Ajjan R. A., & Kotsa K. (2020).  Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?. J Diabetes Sci Technol. 14(4), 745-747.
Makri, E. S., Goulas A., & Polyzos S. A. (2021).  Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease.. Eur J Pharmacol. 907, 174272.
Imprialos, K. P., Stavropoulos K., Stavropoulos N., Patoulias D., Petidis K., Grassos C., et al. (2018).  Sodium-glucose Cotransporter 2 Inhibitors: Impact on Body Weight and Blood Pressure Compared with other Antidiabetic Drugs.. Cardiovasc Hematol Disord Drug Targets. 18(2), 104-113.
Vasilakou, D., Karagiannis T., Athanasiadou E., Mainou M., Liakos A., Bekiari E., et al. (2013).  Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.. Ann Intern Med. 159(4), 262-74.
Patoulias, D., Manafis A., Mitas C., Avranas K., Lales G., Zografou I., et al. (2018).  Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice.. Cardiovasc Hematol Disord Drug Targets. 18(2), 139-146.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές